[Guidelines for the diagnosis and management of hepatic encephalopathy in cirrhosis]
- PMID: 30481878
- DOI: 10.3760/cma.j.issn.1007-3418.2018.10.001
[Guidelines for the diagnosis and management of hepatic encephalopathy in cirrhosis]
Abstract
Current guideline developed by the Chinese Society of Hepatology on the management of hepatic encephalopathy in cirrhosis is grounded on the published evidences and panelists' consensus. This guideline presents recommendations for diagnosis and management of covert and overt hepatic encephalopathy, and underline the importance of screening minimal hepatic encephalopathy in patients with end-stage liver diseases. In addition, it also stresses that early identification and timely treatments are the means to know the prognosis. The principles of treatment are primary and secondary prevention, prompt removal of the cause, and recovery of acute neuropsychiatric abnormalities to baseline status.
Keywords: Diagnosis; Hepatic encephalopathy; Liver cirrhosis; Therapy.
Similar articles
-
[Guidelines on the management of hepatic encephalopathy in cirrhosis].Zhonghua Nei Ke Za Zhi. 2018 Oct 1;57(10):705-718. doi: 10.3760/cma.j.issn.0578-1426.2018.10.004. Zhonghua Nei Ke Za Zhi. 2018. PMID: 30293330 Chinese.
-
Chinese guidelines on management of hepatic encephalopathy in cirrhosis.World J Gastroenterol. 2019 Sep 28;25(36):5403-5422. doi: 10.3748/wjg.v25.i36.5403. World J Gastroenterol. 2019. PMID: 31576089 Free PMC article.
-
Optimal treatment of hepatic encephalopathy.Minerva Gastroenterol Dietol. 2014 Mar;60(1):55-70. Minerva Gastroenterol Dietol. 2014. PMID: 24632768 Review.
-
Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.Clin Ther. 2013 Sep;35(9):1458-73. doi: 10.1016/j.clinthera.2013.07.421. Epub 2013 Aug 22. Clin Ther. 2013. PMID: 23972578 Review.
-
Update on management of patients with overt hepatic encephalopathy.Hosp Pract (1995). 2013 Aug;41(3):48-59. doi: 10.3810/hp.2013.08.1068. Hosp Pract (1995). 2013. PMID: 23948621 Review.
Cited by
-
Rifaximin Modulates the Gut Microbiota to Prevent Hepatic Encephalopathy in Liver Cirrhosis Without Impacting the Resistome.Front Cell Infect Microbiol. 2022 Jan 18;11:761192. doi: 10.3389/fcimb.2021.761192. eCollection 2021. Front Cell Infect Microbiol. 2022. PMID: 35118004 Free PMC article.
-
Role of chitinase-3-like protein 1 in liver diseases: A comprehensive review.Genes Dis. 2025 Apr 24;12(6):101653. doi: 10.1016/j.gendis.2025.101653. eCollection 2025 Nov. Genes Dis. 2025. PMID: 40821115 Free PMC article. Review.
-
Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024).J Clin Transl Hepatol. 2025 Mar 28;13(3):253-267. doi: 10.14218/JCTH.2024.00484. Epub 2025 Feb 17. J Clin Transl Hepatol. 2025. PMID: 40078200 Free PMC article.
-
Analytical and Clinical Evaluation of a Chemiluminescent Immunoassay to Detect Serum Chitinase-3-like Protein 1 in HBV-Related Liver Diseases.Int J Anal Chem. 2024 Jan 24;2024:6688819. doi: 10.1155/2024/6688819. eCollection 2024. Int J Anal Chem. 2024. PMID: 38304922 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical